River Road Asset Management LLC Takes Position in Smith & Nephew plc (NYSE:SNN)

River Road Asset Management LLC purchased a new position in shares of Smith & Nephew plc (NYSE:SNN) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,239,187 shares of the medical equipment provider’s stock, valued at approximately $38,588,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brandes Investment Partners LP boosted its position in shares of Smith & Nephew by 20.5% during the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after buying an additional 233,293 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Smith & Nephew by 355.8% in the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock valued at $31,059,000 after acquiring an additional 964,762 shares during the period. Hsbc Holdings PLC lifted its holdings in shares of Smith & Nephew by 18.9% in the 2nd quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock worth $13,607,000 after acquiring an additional 87,360 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after purchasing an additional 193,046 shares during the period. Finally, Deprince Race & Zollo Inc. grew its holdings in Smith & Nephew by 94.2% during the 2nd quarter. Deprince Race & Zollo Inc. now owns 239,245 shares of the medical equipment provider’s stock valued at $5,928,000 after purchasing an additional 116,078 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Stock Up 1.5 %

NYSE SNN opened at $25.67 on Tuesday. The stock’s fifty day moving average price is $29.87 and its 200 day moving average price is $27.85. Smith & Nephew plc has a 1 year low of $23.65 and a 1 year high of $31.72. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on SNN. Deutsche Bank Aktiengesellschaft lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday. StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 5th.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.